Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Breast conservation and neoadjuvant chemotherapy in breast cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 28.01.19
Views: 648

Prof Michael Douek - King's College London, London, UK

Prof Michael Douek speaks to ecancer at BGICC 2019 in Cairo about neoadjuvant chemotherapy in breast cancer.

He weighs up the main issues for surgeons, breast conservation, and when primary chemotherapy is necessary.

Prof Douek emphasises that there needs to be more level one evidence to support the use of neoadjuvant chemotherapy.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation